This Veterans Day, we’re shining a light on care for those who’ve served.Dr. Elizabeth (Betsy) O’Donnell, Director of the Multi-Cancer Early Detection Clinic at Dana-Farber Cancer Institute, joins the PQI Podcast to discuss the Sentinel Study—a Department of Defense–sponsored clinical trial offering multi-cancer early detection (MCED) testing to U.S. veterans.Through a single blood draw, the test can screen for more than 50 types of cancer, addressing the urgent need for improved screening among veterans, who face a cancer risk nearly 20% higher than the general population.Dr. O’Donnell shares how this innovative study combines science, service, and compassion to bring life-saving research to those who’ve served—and what it could mean for the future of oncology care.Listen to learn more about:How early detection technology is transforming the future of cancer careWhy veterans face unique cancer risks linked to their serviceWhat makes the Sentinel Study a model for accessible, equitable screeningThe personal motivation that drives Dr. O’Donnell’s workFor more information on the Sentinel study or to determine eligibility, visit redcap.link/VeteransScreeningStudy or contact the Sentinel Team at [email protected]

Ver todos los episodios